The Gross Margin of Protalix Biotherapeutics Inc (PLX) is 54.46%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 54.46% |
| 2023-12-31 | 64.91% |
| 2022-12-31 | 58.88% |
| 2021-12-31 | 57.37% |
| 2020-12-31 | 82.72% |
| 2019-12-31 | 80.09% |
| 2018-12-31 | 72.84% |
| 2017-12-31 | 27.75% |
| 2016-12-31 | 8.70% |
| 2015-12-31 | 83.26% |